• October 13, 2022

The earliest reference to therapeutic dry powder inhalation may also be the earliest reference to “engineered particles,” dating from 1849, in London. An initial article looks at the history of dry powder inhalers, including devices and formulations, and discusses considerations for future DPIs. Then an interview takes a new look at current challenges and opportunities […]

  • April 8, 2022

A large gap exists between the relatively straightforward robust methods in the pharmacopeias, developed primarily for product release, and the more elaborate approaches to assist in understanding how inhalers are likely to perform in the hands of the patient or caregiver. The authors propose that there is a middle way forward and believe it is […]

  • January 28, 2019

The author suggests opportunities exist in treating additional diseases, getting involved with patients, determining aerodynamic particle size distribution, managing oropharyngeal deposition, improving nasal delivery and targeting orally inhaled products with narrow therapeutic indices.

  • February 6, 2018

IPAC-RS hopes users will choose topics of interest and that each module will provide an engaging lesson in a manageable format. New modules will be made available online as they are completed.

Follow Savion, age 10, on a journey with the Medikidz superheroes from Mediland, a living, moving planet like the human body. The characters are designed to be fun and appealing to young people so that entertainment and education can happen in tandem.

This online museum helps ensure that some remarkably clever, early ideas for inhalation therapy are not forgotten. The earliest DPI reference now appears to be 1848, predating the Spinhaler by more than 100 years.

In Hawai’i, volcanically-generated smog can result in poor air quality poor air quality comparable with that of Los Angeles or London, UK on a hot summer’s day. About 4.4% (age-adjusted = 4.2%) of Hawai’i residents have been told by a healthcare professional they have COPD. A 2010 report noted that social, economic and demographic variation, […]

We need a substantial shift in the current approach to pMDI training and goals to achieve beyond new training aids. Training should not be an intermittent review process but become a routine part of “taking medicine.” The capability to train should no longer be a poor relation but be properly recompensed. Training aid companies need […]

  • November 29, 2017

Attending Respiratory Drug Delivery (RDD) meetings can help you develop new contacts or give old friends and colleagues a chance to catch up on the latest scientific, clinical and business developments. Since 1988, RDD meetings have provided a venue for leading academic and industry scientists to share information on aerosol pharmaceutical development.

  • November 14, 2017

Recognizing a need for timely, low-cost basic training in inhaled drug delivery, RDD Online decided recently to develop a series of unbiased, modular, web-based training presentations. While many universities and healthcare providers are using the modules, the online training may prove particularly helpful for pharmaceutical companies that need to meet regulatory requirements to assess and […]